Johnson & Johnson (JNJ) After 55% Surge: Is It Still a Value Play?
Johnson & Johnson (JNJ) surged 55.6% over the past year to close at US$235.66. This article examines whether the stock still offers value or is now fully priced, reviewing recent performance and key metrics.
Key Numbers
Johnson & Johnson (JNJ) has surged 55.6% over the past year to close at US$235.66, prompting investors to question whether the stock remains a good deal or is now fully valued. This article walks through the numbers to help assess the current valuation.
Recent Stock Performance
The stock has shown positive returns across various timeframes:
| Period | Return |
|---|---|
| 7 days | 1.5% |
| 30 days | 3.9% |
| Year-to-date | 13.7% |
| 1 year | 55.6% |
| 3 years | 56.6% |
| 5 years | 65.6% |
Valuation Assessment
At US$235.66, investors need to consider the company's fundamentals to determine if the stock remains undervalued. Key factors include earnings growth, cash flows, and dividend yield. The original article did not provide a specific fair value estimate.
What This Means for Investors
The decision to invest in JNJ depends on individual assessment of future growth potential relative to the current price. A thorough fundamental analysis is recommended before making any investment decision.
Frequently Asked Questions
Found this useful? Share it